Latest from Kromek

CEO Arnab Basu joins DirectorsTalk to discuss its DARPA-sponsored project to develop device and technology to detect and identify pathogens in an urban environment. Arnab explains what the project entails, what this means for the company, confidence on delivering on time and what else investors should be looking out for over the coming months.

Kromek is pleased to announce that it has been awarded an extension to its contract by the Defense Advanced Research Projects Agency (“DARPA”), an agency of the US Department of Defense, to detect and identify pathogens in an urban environment.

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, provides an update on trading for the 12-month period ended 30 April 2020 and its business response to COVID-19.

Kromek is delighted to announce that it has received a Queen’s Award for Enterprise in recognition of its outstanding contribution to International Trade.

Kromek is pleased to announce that it intends to commence the manufacture and sale of medical ventilators in the UK and globally under license from Metran Co., Ltd (“Metran”), a Japan-based leading developer of medical ventilator products and technology, to support the COVID19 response.

Kromek is now using 100% green and renewable energy